Clinical impact of genomic characterization of 15 patients with acute
megakaryoblastic leukemia related malignancies
Abstract
Background: Acute megakaryoblastic leukemia (AMKL) is a rare subtype of
acute myeloid leukemia but is ~500 times more likely to
develop in children with Down syndrome (DS) thro